GitLab (GTLB) 10-Q 5 Sep 23 2024 Q2 Quarterly report Financial data

Cover

Cover - shares shares in Millions	6 Months Ended
	Jul. 31, 2023	Aug. 25, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2023
Document Transition Report	false
Entity File Number	001-40895
Entity Registrant Name	GITLAB INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-1861035
Title of 12(b) Security	Class A common stock, par value $0.0000025per share
Trading Symbol	GTLB
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Address, Address Line One	251 Little Falls Drive
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19808
Entity Central Index Key	0001653482
Current Fiscal Year End Date	--01-31
Current Fiscal Year Focus	2024
Current Fiscal Period Focus	Q2
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		104.1
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		50.6

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Jul. 31, 2023		Jan. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	[1]	$ 273,225		$ 295,402
Short-term investments	[1]	713,058		641,249
Accounts receivable, net of allowance for doubtful accounts of $180 and $1,564 as of July 31, 2023 and January 31, 2023, respectively	[1]	105,815		130,479
Deferred contract acquisition costs, current	[1]	25,069		26,505
Prepaid expenses and other current assets	[1]	26,053		24,327
Total current assets	[1]	1,143,220		1,117,962
Property and equipment, net	[1]	4,080		5,797
Operating lease right-of-use assets		673	[1]	998
Equity method investment	[1]	10,574		12,682
Goodwill	[1]	8,145		8,145
Intangible assets, net	[1]	2,774		3,901
Deferred contract acquisition costs, non-current	[1]	14,743		15,628
Other long-term assets	[1]	4,860		4,087
TOTAL ASSETS	[1]	1,189,069		1,169,200
CURRENT LIABILITIES:
Accounts payable	[1]	4,165		5,184
Accrued expenses and other current liabilities	[1]	24,643		25,954
Accrued compensation and benefits	[1]	23,504		20,776
Deferred revenue, current	[1]	268,883		254,382
Total current liabilities	[1]	321,195		306,296
Deferred revenue, non-current	[1]	25,860		28,355
Other non-current liabilities	[1]	10,774		9,824
TOTAL LIABILITIES	[1]	357,829		344,475
Commitments and contingencies (Note 15)	[1]
STOCKHOLDERS’ EQUITY:
Preferred stock, $0.0000025 par value; 50,000 shares authorized as of July 31, 2023 and January 31, 2023; no shares issued and outstanding as of July 31, 2023 and January 31, 2023	[1]	0		0
Additional paid-in capital	[1]	1,610,072		1,497,373
Accumulated deficit	[1]	(828,197)		(725,648)
Accumulated other comprehensive income (loss)	[1]	1,782		(705)
Total GitLab stockholders’ equity	[1]	783,657		771,020
Noncontrolling interests	[1]	47,583		53,705
TOTAL STOCKHOLDERS’ EQUITY	[1]	831,240		824,725
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	[1]	1,189,069		1,169,200
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	[1]	0		0
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	[1]	$ 0		$ 0
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands		Jul. 31, 2023	Jan. 31, 2023
Allowance for doubtful accounts		$ 180	$ 1,564
STOCKHOLDERS’ EQUITY:
Preferred stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Preferred stock, shares authorized (in shares)		50,000,000	50,000,000
Preferred stock, shares issued (in shares)		0	0
Preferred stock, shares outstanding (in shares)		0	0
Assets of consolidated variable interest entity	[1]	$ 1,189,069	$ 1,169,200
Liabilities of consolidated variable interest entity	[1]	357,829	344,475
Variable Interest Entity, Primary Beneficiary
STOCKHOLDERS’ EQUITY:
Assets of consolidated variable interest entity		52,465	62,827
Liabilities of consolidated variable interest entity		$ 7,277	$ 8,871
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Common stock, shares authorized (in shares)		1,500,000,000	1,500,000,000
Common stock, shares issued (in shares)		103,432,000	94,655,000
Common stock, shares outstanding (in shares)		103,432,000	94,655,000
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Common stock, shares authorized (in shares)		250,000,000	250,000,000
Common stock, shares issued (in shares)		51,178,000	56,489,000
Common stock, shares outstanding (in shares)		51,178,000	56,489,000
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenue	$ 139,581	$ 101,041	$ 266,459	$ 188,448
Cost of revenue	14,696	13,030	28,635	22,878
Gross profit	124,885	88,011	237,824	165,570
Operating expenses:
Sales and marketing	92,116	80,689	178,653	147,399
Research and development	49,007	39,520	99,394	71,350
General and administrative	37,819	33,104	72,067	54,996
Total operating expenses	178,942	153,313	350,114	273,745
Loss from operations	(54,057)	(65,302)	(112,290)	(108,175)
Interest income	9,112	3,064	16,427	3,590
Other income (expense), net	(1,330)	1,500	(1,077)	19,948
Loss before income taxes and loss from equity method investment	(46,275)	(60,738)	(96,940)	(84,637)
Loss from equity method investment, net of tax	(917)	(816)	(1,665)	(1,019)
Provision for (benefit from) income taxes	4,016	(57)	5,502	2,454
Net loss	(51,208)	(61,497)	(104,107)	(88,110)
Net loss attributable to noncontrolling interest	(1,128)	(2,473)	(1,558)	(2,987)
Net loss attributable to GitLab	$ (50,080)	$ (59,024)	$ (102,549)	$ (85,123)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)	$ (0.33)	$ (0.40)	$ (0.67)	$ (0.58)
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)	$ (0.33)	$ (0.40)	$ (0.67)	$ (0.58)
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in shares)	153,644,000	147,797,000	152,683,000	147,248,000
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in shares)	153,644,000	147,797,000	152,683,000	147,248,000
Subscription—self-managed and SaaS
Revenue	$ 122,096	$ 88,936	$ 233,287	$ 165,859
Cost of revenue	10,871	10,671	21,762	18,604
License—self-managed and other
Revenue	17,485	12,105	33,172	22,589
Cost of revenue	$ 3,825	$ 2,359	$ 6,873	$ 4,274

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (51,208)	$ (61,497)	$ (104,107)	$ (88,110)
Foreign currency translation adjustments	(365)	(1,128)	(1,222)	(3,792)
Net change in unrealized gains (losses) on available-for-sale securities	(194)	(2,454)	1,303	(2,523)
Comprehensive loss including noncontrolling interest	(51,767)	(65,079)	(104,026)	(94,425)
Net loss attributable to noncontrolling interest	(1,128)	(2,473)	(1,558)	(2,987)
Foreign currency translation adjustments attributable to noncontrolling interest	(1,338)	(732)	(2,406)	(2,047)
Comprehensive loss attributable to noncontrolling interest	(2,466)	(3,205)	(3,964)	(5,034)
Comprehensive loss attributable to GitLab	$ (49,301)	$ (61,874)	$ (100,062)	$ (89,391)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total		Class A Common Stock	Common stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 799,269				$ 0	$ 0	$ 1,320,479	$ (553,337)	$ 7,724	$ 24,403
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2022					27,141,000	119,747,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					55,368,000	(55,368,000)
Issuance of common stock related to vested exercised stock options (in shares)						1,386,000
Issuance of common stock related to vested exercised stock options	11,413						11,413
Issuance of common stock under employee stock purchase plan (in shares)					289,000
Issuance of common stock under employee stock purchase plan	9,554						9,554
Repurchases, net of early exercised stock options (in shares)						(19,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					227,000
Vesting of early exercised stock options	2,960						2,960
Stock-based compensation expense	55,218						52,246			2,972
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	57,673						16,839			40,834
Deconsolidation of Meltano Inc.	(11,342)									(11,342)
Other comprehensive income (loss)	(6,315)								(4,268)	(2,047)
Net loss	(88,110)							(85,123)		(2,987)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2022					83,025,000	65,746,000
Stockholders' Equity, ending balance at Jul. 31, 2022	830,320				$ 0	$ 0	1,413,491	(638,460)	3,456	51,833
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	818,202				$ 0	$ 0	1,355,224	(579,436)	6,306	36,108
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2022					74,049,000	73,583,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					8,461,000	(8,461,000)
Issuance of common stock related to vested exercised stock options (in shares)						652,000
Issuance of common stock related to vested exercised stock options	6,193						6,193
Issuance of common stock under employee stock purchase plan (in shares)					289,000
Issuance of common stock under employee stock purchase plan	9,554						9,554
Repurchases, net of early exercised stock options (in shares)						(28,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					226,000
Vesting of early exercised stock options	814						814
Stock-based compensation expense	37,747						34,992			2,755
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	22,889						6,714			16,175
Other comprehensive income (loss)	(3,582)								(2,850)	(732)
Net loss	(61,497)							(59,024)		(2,473)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2022					83,025,000	65,746,000
Stockholders' Equity, ending balance at Jul. 31, 2022	830,320				$ 0	$ 0	1,413,491	(638,460)	3,456	51,833
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	830,320				0	0	1,413,491	(638,460)	3,456	51,833
Stockholders' Equity, beginning balance	$ 824,725	[1]			$ 0	$ 0	1,497,373	(725,648)	(705)	53,705
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023					94,655,000	56,489,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					7,358,000	(7,358,000)
Issuance of common stock related to vested exercised stock options (in shares)	2,062,000					2,060,000
Issuance of common stock related to vested exercised stock options	$ 17,933						17,933
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(13,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					1,038,000
Charitable donation of common stock (in shares)			133,389	134,000
Charitable donation of common stock	5,350		$ 5,300				5,350
Vesting of early exercised stock options	809						809
Stock-based compensation expense	78,698						81,359			(2,661)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs							(503)			503
Other comprehensive income (loss)	81								2,487	(2,406)
Net loss	(104,107)							(102,549)		(1,558)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Stockholders' Equity, ending balance at Jul. 31, 2023	831,240	[1]			$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	815,601				$ 0	$ 0	1,542,603	(778,117)	1,003	50,112
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2023					96,240,000	56,453,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)					6,213,000	(6,213,000)
Issuance of common stock related to vested exercised stock options (in shares)						940,000
Issuance of common stock related to vested exercised stock options	10,320						10,320
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(2,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)					679,000
Charitable donation of common stock (in shares)			52,647	53,000
Charitable donation of common stock	2,675		$ 2,700				2,675
Vesting of early exercised stock options	292						292
Stock-based compensation expense	46,368						46,555			(187)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs							(124)			124
Other comprehensive income (loss)	(559)								779	(1,338)
Net loss	(51,208)							(50,080)		(1,128)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Stockholders' Equity, ending balance at Jul. 31, 2023	831,240	[1]			$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 831,240	[1]			$ 0	$ 0	$ 1,610,072	$ (828,197)	$ 1,782	$ 47,583
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023		Jul. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (104,107)		$ (88,110)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	78,698		55,218
Charitable donation of common stock	5,350		0
Amortization of intangible assets	1,125		1,176
Depreciation expense	2,206		1,286
Amortization of deferred contract acquisition costs	20,619		21,618
Gain from deconsolidation of Meltano Inc.	0		(17,798)
Loss from equity method investment	2,108		1,290
Net amortization of premiums or discounts on short-term investments	(8,494)		(1,293)
Unrealized foreign exchange loss (gain), net	825		(1,572)
Other non-cash (income) expense, net	(103)		469
Changes in assets and liabilities:
Accounts receivable	25,281		(13,568)
Prepaid expenses and other current assets	(4,248)		(5,488)
Deferred contract acquisition costs	(18,137)		(21,210)
Other long-term assets	(721)		2,700
Accounts payable	(1,023)		528
Accrued expenses and other current liabilities	1,183		90
Accrued compensation and benefits	2,611		(16,680)
Deferred revenue	11,175		17,549
Other non-current liabilities	1,800		(696)
Net cash provided by (used in) operating activities	16,148		(64,491)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(334,996)		(520,664)
Proceeds from maturities of short-term investments	272,984		50,031
Purchases of property and equipment	(533)		(3,234)
Deconsolidation of Meltano Inc.	0		(9,620)
Escrow payment related to business combination, after acquisition date	2,500		0
Net cash used in investing activities	(65,045)		(483,487)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	17,777		11,311
Issuance of common stock under employee stock purchase plan	7,751		9,554
Contributions received from noncontrolling interests, net of issuance costs	0		57,673
Net cash provided by financing activities	25,528		78,538
Impact of foreign exchange on cash and cash equivalents	(1,308)		(4,475)
Net decrease in cash and cash equivalents	(24,677)		(473,915)
Cash, cash equivalents, and restricted cash at beginning of period	297,902		887,172
Cash, cash equivalents, and restricted cash at end of period	273,225		413,257
Supplemental disclosure of cash flow information:
Cash paid for income taxes	4,187		309
Supplemental disclosure of non-cash investing and financing activities:
Vesting of early exercised stock options	809		2,960
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	273,225	[1]	410,757
Restricted cash, included in prepaid expenses and other current assets	0		2,500
Total cash, cash equivalents and restricted cash	$ 273,225		$ 413,257
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business GitLab Inc. (the “Company”) began as an open source project in 2011 and was incorporated in Delaware on September 12, 2014. While the Company is headquartered in San Francisco, California, it operates on an all-remote model. The Company is a technology company and its primary offering is “GitLab”, a complete DevSecOps platform delivered as a single application. GitLab is used by a wide range of organizations. The Company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service ("SaaS") models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The Company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world to help them become better software-led businesses.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal 2024 and 2023 refer to the fiscal year ending January 31, 2024 and the fiscal year ended January 31, 2023, respectively. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes, reserves for unrealized income tax benefits, valuation of intangibles assets and impairment of goodwill and equity method investments. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation. Summary of Significant Accounting Policies There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2” of the Company’s Annual Report on Form 10-K f or the fiscal year ended January 31, 2023.

Revenues

Revenues	6 Months Ended
	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenues	3. Revenues Disaggregation of Revenue The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Subscription—self-managed and SaaS $ 122,096 87 % $ 88,936 88 % $ 233,287 87 % $ 165,859 88 % Subscription—self-managed 86,659 62 66,896 66 166,246 62 126,615 67 SaaS 35,437 25 22,040 22 67,041 25 39,244 21 License—self-managed and other $ 17,485 13 % $ 12,105 12 % $ 33,172 13 % $ 22,589 12 % License—self-managed 14,624 11 10,009 10 27,979 11 18,786 10 Professional services and other 2,861 2 2,096 2 5,193 2 3,803 2 Total revenue $ 139,581 100 % $ 101,041 100 % $ 266,459 100 % $ 188,448 100 % Total Revenue by Geographic Location The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 United States $ 114,054 $ 84,123 $ 217,016 $ 156,397 Europe 22,245 14,750 43,202 27,738 Asia Pacific 3,282 2,168 6,241 4,313 Total revenue $ 139,581 $ 101,041 $ 266,459 $ 188,448 During the three and six months ended July 31, 2023, the United States accounted for 82% and 81% of total revenue, respectively. During each of the three and six months ended July 31, 2022, the United States accounted for 83% of total revenue for each period presented. No other individual country exceeded 10% of total revenue for any of the periods presented. The Company operates its business as a single reportable segment. Deferred Revenue During the three and six months ended July 31, 2023 , $101.6 million and $157.5 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue bala nce at the beginning of the periods presented. During the three and six months ended July 31, 2022, $67.0 million and $105.8 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the periods presented. Remaining Performance Obligations As of July 31, 2023 and January 31, 2023, the aggregate amount of the transaction price allocated to billed and unbilled remaining performance obligations for which revenue has not yet been recognized was approximately $495.8 million and $435.9 million, respectively. As of July 31, 2023, the Company expects to recognize approximately 68% of the transaction price as product or services revenue over the next 12 months and 88% over the next 24 months. Concentration of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these balances. The Company maintains allowances for potential credit losses on accounts receivable when deemed necessary. The Company uses various distribution channels. As of July 31, 2023, one of these channel partners represented 16% of the accounts receivable balance, respectively, while as of January 31, 2023 one of these channel partners represented 12% of the accounts receivable balance. There were no individual customers whose balance represented more than 10% of accounts receivable as of July 31, 2023 and January 31, 2023 . There were no customers whose revenue represented more than 10% of total revenue during the three and six months ended July 31, 2023 and 2022.

Cash, Cash Equivalents and Shor

Cash, Cash Equivalents and Short-Term Investments	6 Months Ended
	Jul. 31, 2023
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents and Short-Term Investments	4. Cash, Cash Equivalents and Short-Term Investments The following table summarizes the Company’s cash, cash equivalents and short-term investments by category (in thousands): As of July 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 126,196 $ — $ — $ 126,196 Money market funds 117,628 — — 117,628 U.S. Treasury securities 18,485 — — 18,485 Commercial paper 10,919 — (3) 10,916 Total cash and cash equivalents $ 273,228 $ — $ (3) $ 273,225 Short-term investments: Commercial paper 83,957 — (77) 83,880 Corporate debt securities 177,000 2 (1,148) 175,854 Foreign government bonds 2,235 — (19) 2,216 U.S. Agency securities 67,567 — (445) 67,122 U.S. Treasury securities 385,848 1 (1,863) 383,986 Total short-term investments $ 716,607 $ 3 $ (3,552) $ 713,058 As of January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 232,332 $ — $ — $ 232,332 Money market funds 60,073 — — 60,073 U.S. Agency securities 2,997 — — 2,997 Total cash and cash equivalents $ 295,402 $ — $ — $ 295,402 Short-term investments: Commercial paper 88,703 18 (112) 88,609 Corporate debt securities 95,805 33 (572) 95,266 Municipal bonds 1,989 — (19) 1,970 Foreign government bonds 2,211 — (41) 2,170 U.S. Agency securities 74,158 2 (435) 73,725 U.S. Treasury securities 383,238 — (3,729) 379,509 Total short-term investments $ 646,104 $ 53 $ (4,908) $ 641,249 The Company uses the specific-identification method to determine an y realized gains or losses from the sale of the Company’s short-term investments classified as available-for-sale. For the three and six months ended July 31, 2023 and 2022, the Company did not have any material realized gains or losses as a result of maturities or sale of short-term investments. During the three and six months ended July 31, 2023, the Company record ed $9.1 million and $16.4 million of interest income on cash equivalents and short-term investments, respectively, which includes $4.9 million and $8.5 million of net amortization of premiums or discounts on short-term investments during the three and six months ended July 31, 2023, respectively. During the three and six months ended July 31, 2022, the Company recorded $3.1 million and $3.6 million of interest income on cash equivalents and short-term investments, respectively, which included $1.3 million of net a mortization of premiums or discounts on short-term investments for each period presented during the three and six months ended July 31, 2022. The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands): Less Than 12 Months More Than 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses July 31, 2023 U.S. Agency securities $ 63,223 $ (444) $ 3,899 $ (1) $ 67,122 $ (445) Commercial paper 86,797 (80) — — 86,797 (80) Corporate debt securities 153,562 (969) 18,869 (179) 172,431 (1,148) Foreign government bonds — — 2,216 (19) 2,216 (19) U.S. Treasury securities 263,148 (906) 92,567 (957) 355,715 (1,863) Total cash equivalents and short-term investments $ 566,730 $ (2,399) $ 117,551 $ (1,156) $ 684,281 $ (3,555) Less Than 12 Months More Than 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses January 31, 2023 U.S. Agency securities $ 73,724 $ (435) $ — $ — $ 73,724 $ (435) Commercial paper 45,015 (112) — — $ 45,015 $ (112) Corporate debt securities 75,203 (572) — — $ 75,203 $ (572) Municipal bonds 1,970 (19) — — $ 1,970 $ (19) Foreign government bonds 2,170 (41) — — $ 2,170 $ (41) U.S. Treasury securities 379,509 (3,729) — — $ 379,509 $ (3,729) Total cash equivalents and short-term investments $ 577,591 $ (4,908) $ — $ — $ 577,591 $ (4,908) The following table classifies the Company’s short-term investments by contractual maturities (in thousands): July 31, 2023 January 31, 2023 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 587,035 $ 584,491 $ 480,943 $ 477,520 Due between 1 year to 2 years 129,572 128,567 165,161 163,729 Total $ 716,607 $ 713,058 $ 646,104 $ 641,249 All available-for-sale securities have been classified as current, based on management’s ability to use the funds in current operations.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. Fair Value Measurements The Company determines fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instrumen ts such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. Financial assets measured at fair value on a recurring basis are summarized below (in thousands): Level 1 Level 2 Level 3 Fair Value July 31, 2023 (1) Cash equivalents: Money market funds $ 117,628 $ — $ — $ 117,628 U.S. Treasury securities — 18,485 — 18,485 Commercial paper — 10,916 — 10,916 Short-term investments: Commercial paper — 83,880 — 83,880 Corporate debt securities — 175,854 — 175,854 Foreign government bonds — 2,216 — 2,216 U.S. Agency securities — 67,122 — 67,122 U.S. Treasury securities — 383,986 — 383,986 Total $ 117,628 $ 742,459 $ — $ 860,087 (1) Excludes $126.2 million in cash on the condensed consolidated balance sheet as of July 31, 2023. Level 1 Level 2 Level 3 Fair Value January 31, 2023 (1) Cash equivalents: Money market funds $ 60,073 $ — $ — $ 60,073 U.S. Agency securities — 2,997 — 2,997 Short-term investments: Commercial paper — 88,609 — 88,609 Corporate debt securities — 95,266 — 95,266 Municipal bonds — 1,970 — 1,970 Foreign government bonds — 2,170 — 2,170 U.S. Agency securities — 73,725 — 73,725 U.S. Treasury securities — 379,509 — 379,509 Total $ 60,073 $ 644,246 $ — $ 704,319 (1) Exclu des $232.3 million in cash on the condensed consolidated balance sheet as of January 31, 2023. The Company had $3.5 million

Supplemental Financial Statemen

Supplemental Financial Statement Information	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Financial Statement Information	6. Supplemental Financial Statement Information Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): July 31, 2023 January 31, 2023 Prepaid software subscriptions $ 6,748 $ 7,771 Prepaid taxes 3,955 592 Prepaid expenses for the Company’s events 1,030 1,885 Prepaid insurance 1,003 3,199 Prepaid advertising costs 532 367 Other prepaid expenses 3,459 1,915 Restricted cash (1) — 2,500 Interest receivable 2,913 2,310 Revenue contract asset 2,473 1,532 Security and other deposits 1,290 510 Other current assets 2,650 1,746 Total prepaid expense and other current assets $ 26,053 $ 24,327 (1) Refer to “Note 7. Business Combination”. Property and Equipment, Net Property and equipment, net of the following (in thousands): July 31, 2023 January 31, 2023 Computer and office equipment $ 9,140 $ 8,581 Leasehold improvements 1,148 1,208 10,288 9,789 Less: Accumulated depreciation (1) (6,208) (3,992) Total property and equipment, net (1) $ 4,080 $ 5,797 (1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment. Depreciation expense of property and equipment was $1.1 million and $2.2 million for the three and six months ended July 31, 2023, respectively. Depreciation expense of property and equipment was $0.7 million and $1.3 million for the three and six months ended July 31, 2022, respectively. Other Long-Term Assets Other long-term assets consisted of the following (in thousands): July 31, 2023 January 31, 2023 Security and other deposits $ 3,377 $ 3,172 Deferred software implementation costs 395 594 Vendor receivables 1,026 132 Other long-term assets 62 189 Total other long-term assets $ 4,860 $ 4,087 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2023 January 31, 2023 Accrued expenses $ 11,547 $ 10,686 Customer refunds payable 3,471 3,465 Income taxes payable 3,455 859 Indirect taxes payable 2,487 4,498 ESPP employee contributions 2,176 2,967 Operating lease liabilities, current 617 716 Acquisition related consideration withheld in escrow (1) — 2,500 Other current liabilities 890 263 Total accrued expenses and other current liabilities $ 24,643 $ 25,954 (1) Refer to “Note 7. Business Combination”. Accrued Com pensation and Benefits Accrued compensation and benefits consisted of the following (in thousands): July 31, 2023 January 31, 2023 Payroll taxes payable $ 5,778 $ 3,013 Accrued commissions 5,067 8,512 Restructuring accrual and related charges (1) 155 — Other accrued team member related payables 12,504 9,251 Total accrued compensation and benefits $ 23,504 $ 20,776 (1) Refer to “Note 11. Restructuring and Other Related Charges”. Other Non-Current Liabilities Other non-current liabilities consisted of the following (in thousands): July 31, 2023 January 31, 2023 Acquisition related contingent cash consideration (1) $ 3,525 $ 3,443 Provision towards labor matters (2) 2,586 2,504 Deferred tax liabilities 758 849 Long term taxes payable 2,792 647 Early exercised options liability 835 1,800 Operating lease liabilities, non-current 138 413 Other non-current liabilities 140 168 Total other non-current liabilities $ 10,774 $ 9,824 (1) Refer to “Note 7. Business Combination”. (2) Refer to “Note 15. Commitments and Contingencies ”. Other Inc ome (Expense), Net Other income, net consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Gain from deconsolidation of Meltano Inc. (1) $ — $ — $ — $ 17,798 Foreign exchange gains (losses), net (1,268) 1,646 (994) 2,506 Other expenses, net (62) (146) (83) (356) Total other income (expense), net $ (1,330) $ 1,500 $ (1,077) $ 19,948 (1) Refer to “Note 12. Joint Venture and Equity Method Investment”.

Business Combination

Business Combination	6 Months Ended
	Jul. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combination	7. Business Combination On December 3, 2021, th e Company completed the acquisition of Opstrace, Inc., a technology company based in San Francisco, California. The transaction was accounted for as a business combination. The acquisition date fair value of the consideration transferred was $13.5 million, which included contingent cash consideration. As of January 31, 2023, t he Company held $2.5 million in an escrow as partial security for post-closing indemnification claims made within 18 months of the closing da te. The Company fully paid this acquisition-related holdback during the three months ended July 31, 2023. In September 2022, one of the operational milestones was achieved and the Company paid $4.2 million of contingent cash consideration. The remaining contingent cash consideration is determined based upon the satisfaction of certain defined operational milestones and remeasured at fair value at each reporting period through earnings. During the three and six months ended July 31, 2023 and 2022, the Company did not record any changes to the fair value of the contingent cash consideration. As the fair value is based on unobservable inputs, the liability is included in Level 3 of the fair value measurement hierarchy. As of July 31, 2023 and January 31, 2023, the Company had recorde d $3.5 million of remaining contingent cash consideration which is included in other long term liabilities on the respective condensed consolidated balance sheets. Accretion expense was immaterial and $0.1 million for the three and six months ended July 31, 2023, respectively, and $0.1 million and $0.2 million for the three and six months ended July 31, 2022, respectively.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	6 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	8. Goodwill and Intangible Assets, Net Goodwill The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of July 31, 2023 and January 31, 2023 $ 8,145 There was no goodwill impairment for any periods presented. Intangible Assets Intangible assets, net consisted of the following (in thousands): July 31, 2023 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (3,426) $ 2,774 1.3 Developed technology from asset acquisitions (1) (2) 932 (932) — 0.0 Total $ 7,132 $ (4,358) $ 2,774 January 31, 2023 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (2,401) $ 3,799 1.8 Developed technology from asset acquisitions (1) 1,359 (1,257) 102 0.3 Total $ 7,559 $ (3,658) $ 3,901 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles. (2) During the three months ended July 31, 2023 , t he Company wrote off $0.5 million of fully amortized intangible assets as the technology had become obsolete. Amortization expense was $0.5 million and $1.1 million for the three and six months ended July 31, 2023, respectively, and $0.6 million and $1.2 million for the three and six months ended July 31, 2022, respectively. As of July 31, 2023, future a mortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2024 $ 1,039 2025 1,735 Total future amortization $ 2,774

Team Member Benefit Plans

Team Member Benefit Plans	6 Months Ended
	Jul. 31, 2023
Retirement Benefits [Abstract]
Team Member Benefit Plans	9. Team Member Benefit Plans The Company contributes to defined c ontribution plans in a number of countries including a 401(k) savings plan for U.S. based team members and defined contribution arrangements in the United Kingdom, Australia, New Zealand and select other countries based on the legislative and tax requirements of the respective countries. Total contributions to these plans were $1.0 million and

Equity

Equity	6 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Equity	10. Equity In connection with the Company’s initial public offering (the “IPO”), on October 18, 2021, the Company filed a restated certificate of incorporation that authorized the issuance of 1,500,000,000 shares of Class A common stock, 250,000,000 shares of Class B common stock, and 50,000,000 shares of preferred stock at $0.0000025 par value for each class of shares. Common stockholders are entitled to dividends when and if declared by the board of directors. No dividends have been declared to date. The holder of each share of Class A common stock is entitled to one vote and the holder of each share of Class B common stock is entitled to ten votes. Common Stock The Company had shares of common stock reserved for future issuance as follows (in thousands): July 31, 2023 January 31, 2023 Class A and Class B common stock Options issued and outstanding 9,933 12,686 Shares available for issuance under Equity Incentive Plans 25,669 21,483 RSUs and PSUs issued and outstanding 11,376 8,336 Shares reserved for issuance to charitable organizations 1,502 1,636 ESPP 5,567 4,303 Total 54,047 48,444 Early Exercised Options (subject to a repurchase right) Certain stock option holders have the right to exercise unvested options, subject to a repurchase right held by the Company at the original exercise price, in the event of voluntary or involuntary termination of employment of the holder. As of July 31, 2023 and January 31, 2023 , there were 62,712 and 194,304 shares, respectively, of unvested options that had been early exercised and were subject to repurchase for a total liability of $0.8 million and $1.8 million, respectively. The liability as sociated with early exercised options is included in other non-current liabilities in the condensed consolidated balance sheets. For accounting purposes, issuance of shares will be recognized only on vesting. However, shares issued for the early exercise of options are included in issued and outstanding shares as they are legally issued and outstanding. Equity Incentive Plans In 2015, the Company adopted the 2015 Equity Incentive Plan (the “2015 Plan”), in which shares of common stock of the Company are reserved for issuance of stock options to team members, directors, or consultants. The options generally vest 25% upon completion of one year and then ratably over 36 months. Options generally expire ten years from the date of grant. All these options qualify as equity settled awards and contain no performance conditions. In September 2021, in connection with the IPO, the board of directors and stockholders approved the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor to the Company’s 2015 Plan (together the “Plans”). The 2021 Plan authorizes the award of both stock options, which are intended to qualify for tax treatment under Section 422 of the Internal Revenue Code, and nonqualified stock options, as well for the award of restricted stock awards (“RSAs”), stock appreciation rights (“SARs”), restricted stock units (“RSUs”), performance stock units (“PSUs”) and stock bonus awards. Pursuant to the 2021 Plan, incentive stock options may be granted only to the Company’s team members. The Company may grant all other types of awards to its team members, directors, and consultants. The Company initially reserved 13,032,289 shares of its Class A common stock, plus any reserved shares of Class B common stock not issued or subject to outstanding grants under the 2015 Plan on the effective date of the 2021 Plan, for issuance as Class A common stock pursuant to awards granted under the 2021 Plan. The number of shares reserved for issuance under the 2021 Plan increases automatically on February 1 of each of the years from 2022 through 2031. The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): July 31, 2023 January 31, 2023 Available at beginning of period 21,483 18,248 Awards authorized 7,557 7,673 RSUs and PSUs granted (4,843) (6,651) RSUs and PSUs canceled and forfeited 766 657 Options canceled and forfeited 691 1,496 Options repurchased 15 60 Available at end of period 25,669 21,483 In the event that shares previously issued u nder the above Plans are reacquire d by the Company, such shares shall be added to the number of shares then available for issuance under the 2021 Plan. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of su ch stock option will be added to the number of shares then available for issuance under the 2021 Plan. Both Plans allow the grantees to early exercise stock options. Stock Options, RSUs and PSUs The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2023 12,686 $ 12.30 7.00 $ 470.8 Options granted — — Options exercised (2,062) 8.74 Options canceled (198) 9.76 Options forfeited (493) 16.96 Balances at July 31, 2023 9,933 $ 12.80 6.56 $ 372.3 Options vested at July 31, 2023 6,528 $ 10.66 6.17 $ 254.4 Options vested and expected to vest at July 31, 2023 9,933 $ 12.80 6.56 $ 372.3 No options were granted during each of the three months ended July 31, 2023 and 2022. The aggregate intrinsic value of options exercised during the three months ended July 31, 2023 and 2022 was $33.3 million and $25.8 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the fair value of the underlying common stock on the date of exercise. No options were granted during each of the six months ended July 31, 2023 and 2022. The aggregate intrinsic value of options exercised during the six months ended July 31, 2023 and 2022 was $65.9 million and $59.8 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the fair value of the underlying common stock on the date of exercise. As of July 31, 2023 and January 31, 2023, approximately $32.0 million and $46.2 million, respectively, of total unrecognized compensation cost was related to stock options granted, that is expected to be recognized over a weighted-average period of 1.8 a nd 2.1 years, respectively. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. The following table summarizes the Company’s RSU activity (in thousands): Number of Shares (1) Weighted- Balances at January 31, 2023 5,018 $ 53.33 Granted 4,843 39.91 Vested (1,037) 49.97 Canceled/forfeited (677) 52.08 Balances at July 31, 2023 8,147 $ 45.90 (1) The table above does not include 3 million RSUs issued to the Company’s founder and the Chief Executive Officer (“CEO”) described below. These RSUs are grants of shares of the Company’s common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest over two As of July 31, 2023 and January 31, 2023, approximately $362.0 million and $254.8 million, respectively, of total unrecognized compensation cost was related to RSUs granted to team members other than the CEO, that is expected to be recognized over a weighted-average period of 3.3 and 3.2 years, respectively. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. In June 2022, the Company granted 0.4 million PSUs to senior members of its management team subject to revenue performance condition and service conditions. The number of awards granted represents 100% of the target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the original grant. The performance condition is set to be achieved in fiscal 2025 and the service condition in the calendar year 2025. As a result of forfeitures triggered by the departure of a key executive during the three and six months ended July 31, 2023, the Company reversed stock-based compensation previously recorded for that key executive. The Company recorded a $0.1 million gain and $0.3 million of stock-based compensation expense related to PSUs during the three and six months ended July 31, 2023, respectively. As of July 31, 2023, unrecognized stock-based compensation expense related to these PSUs w as $6.3 million to be recognized over a period of 2.4 years. CEO Performance Award In May 2021, the Company granted 3 million RSUs tied to its Class B common stock to Sytse Sijbrandij, the Company’s co-founder and CEO, with an estimated aggregate grant date fair value of $8.8 million. During the three and six months ended July 31, 2023, the Company record ed $0.4 million and $0.8 million of stock-based compensation expense related to the CEO RSUs, respectively. During the three and six months ended July 31, 2022, the Company recorded $0.4 million and $0.8 million of stock-based compensation expense related to the CEO RSUs, respectively. As measured from the grant date, the derived service period of the respective tranches ranges from 2 to 7 years. As of July 31, 2023, unrecognized stock-based compensation expense related to these RSUs was $5.1 million which will be recognized over 5.3 years. 2021 Employee Stock Purchase Plan (“ESPP”) In September 2021, the Company’s board of directors and its stockholders approved the ESPP and participation of eligible team members. During the quarter ended July 31, 2023, the Company’s stock price on the purchase date, May 31, 2023, was lower than the Company’s stock price on the previously applicable offering date. As a result, the offering in effect was reset with the lower stock price becoming the new offering price and rolled over to a new 24-month offering period. The reset was treated as a modification resulting in incremental expense totaling $9.4 million, which is being recognized over the remaining requisite service period as of the date of reset. During the quarter ended July 31, 2022, the Company’s stock price on the purchase date, May 31, 2022, was lower than the Company’s stock price on the previously applicable offering date. As a result, the offering in effect was reset with the lower stock price becoming the new offering price and rolled over to a new 24-month offering period. The reset was treated as a modification resulting in incremental expense totaling $9.9 million , which is being recognized over the remaining requisite service period as of the date of reset. The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model: Six Months Ended July 31, 2023 2022 Risk-free interest rate 4.22% - 5.30% 1.62% - 2.63% Volatility 40.95% - 51.00% 44.95% - 52.76% Expected term (in years) 0.50 - 2.00 0.50 - 2.00 Dividend yield —% —% The Company record ed $6.7 million and $11.2 million of stock-based compensation expense related to the ESPP during the three and six months ended July 31, 2023 , respectively. The Company record ed $9.7 million and $14.1 million of stock-based compensation expense related to the ESPP during the three and six months ended July 31, 2022, respectively. As of July 31, 2023, approximate ly $19.8 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.8 years. Stock-Based Compensation Expense The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Cost of revenue $ 1,698 $ 1,585 $ 3,112 $ 2,375 Research and development 12,477 11,339 24,179 16,375 Sales and marketing 21,295 14,851 35,059 21,902 General and administrative 10,898 9,972 16,348 14,566 Total stock-based compensation expense (1) $ 46,368 $ 37,747 $ 78,698 $ 55,218 (1) The table above includes stock-based compensation of JiHu. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion. The corporate income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation expense w as $3.6 million and $6.4 million for the three and six months ended July 31, 2023 , respectively. The corporate income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation expense was $2.2 million and $3.1 million for the three and six months ended July 31, 2022, respectively. Charitable Donation of Common Stock In September 2021, the Company’s board of directors approved the reservation of up to 1,635,545 shares of Class A common stock for issuance to charitable organizations. In March 2023, the Company’s board of directors approved the donation of $10.7 million aggregate principal amount of shares of Class A common stock to GitLab Foundation (the “Foundation”), a California nonprofit public benefit corporation. The Foundation is also a related party as certain of the Company’s officers serve as directors of the Foundation. This donation shall occur in equal quarterly distributions throughout fiscal 2024. During the three and six months ended July 31, 2023, the Company donated 52,647 shares and 133,389 shares of Class A common stock at fair value to the Foundation, respectively. The fair value of the common stock was determined based on the quoted market price on the grant date. The donation expense of $2.7 million and $5.3 million was re corded in general and administrative expense in the condensed consolidated statements of operations for the three and six months ended July 31, 2023, respectively.

Restructuring and Other Related

Restructuring and Other Related Charges	6 Months Ended
	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Other Related Charges	11. Restructuring and Other Related Charges During the three months ended April 30, 2023, the Company reduced its total global headcount by approximately 7% . As a result, the Company recognized total restructuring charges of approximately $9.1 million in the six months ended July 31, 2023, which consisted primarily of one-time severance and other termination benefit costs of $7.8 million, as well as accelerated stock-based compensation of $1.3 million. The Company recognized one-time severance and other termination benefit costs as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2023 Cost of revenue $ 46 $ 463 Research and development (12) 2,047 Sales and marketing 118 3,677 General and administrative 20 1,638 Total (1) $ 172 $ 7,825 (1) Excludes stock-based compensation of $1.3 million. The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands) : Balance as of January 31, 2023 $ — Charges (1) 7,825 Cash payments (7,670) Balance as of July 31, 2023 (2) $ 155 (1) Excludes stock-based compensation of $1.3 million. (2) $0.2 million is included in accrued compensation and benefits on the condensed consolidated balance sheet as of July 31, 2023.

Joint Venture and Equity Method

Joint Venture and Equity Method Investment	6 Months Ended
	Jul. 31, 2023
Noncontrolling Interest [Abstract]
Joint Venture and Equity Method Investment	12. Joint Venture and Equity Method Investment Joint Venture In February 2021, the Company along with Sequoia CBC Junyuan (Hubei) Equity Investment Partnership (Limited Partnership) and Suzhou Gaocheng Xinjian Equity Investment Fund Partnership (Limited Partnership) executed an investment agreement (the “Investment Agreement”) to establish GitLab Information Technology (Hubei) Co., LTD (“JiHu”), a legal entity in the People’s Republic of China. The Company accounted for JiHu as a variable interest entity and consolidated the entity in accordance with ASC Topic 810, Consolidation . During fiscal year 2023, JiHu closed its Series A-1 through A-3 rounds of common stock financings where investors contributed a total of $54.6 million, net of issuance costs. In March 2022, one of the potential investors who could not participate in the Series A-1 financing round provided a $2.9 million loan to JiHu as an advance pending a capital contribution. The loan was repayable within ten business days of receipt of capital contribution from the investor. JiHu received an equity contribution from this investor during the Series A-2 round and repaid the loan in full in July 2022. Subsequent to the closing of the financing rounds d uring fiscal year 2023 , the Company retained control over JiHu with its equity stake reduced from 72% to 55% . As of July 31, 2023, the Company still retains control over JiHu with its equity stake at approximatel y 55%. In April 2022, the board of directors of JiHu approved an employee stock option plan (“JiHu ESOP”) for its employees. As a result of forfeitures triggered by the departure of certain executives during the three and six months ended July 31, 2023, the Company reversed stock-based compensation previously recorded for such executives. The Company recorded a $0.2 million and $2.7 million gain for the three and six months ended July 31, 2023, respectively. For the three and six months ended July 31, 2022, the Company recorded $2.8 million and $3.0 million of stock-based compensation expense, respectively. As of July 31, 2023, approximately $4.3 million of total unrecognized compensation cost was related to the JiHu ESOP that is expected to be recognized over 2.7 years. The Company considers the RSAs and stock option awards granted pursuant to the JiHu ESOP as potentially dilutive equity instruments that will result in dilution of the Company’s stake in JiHu upon vesting of such award (or, in the case of option awards granted pursuant to the JiHu ESOP, upon vesting and subsequent exercise into shares of JiHu common stock). Any such dilution will be accounted for as an equity transaction. Until such awards granted pursuant to the JiHu ESOP are vested (or, in the case of option awards, vested and ultimately exercised into shares of JiHu common stock), the Company will continue to record the recognized stock-compensation expense of JiHu as part of the noncontrolling interest. Operating Leases The Company recognized $0.1 million and $0.3 million of operating lease expense during the three and six months ended July 31, 2023, respectively, and $0.2 million and $0.3 million of operating lease expense during the three and six months ended July 31, 2022, respectively. JiHu has non-cancelable operating leases maturing over the next two years with total lease payments of $0.7 million and total present value of lease liabilities of $0.7 million. Lease expense for the one short-term lease was immaterial during each of the three and six months ended July 31, 2023 and 2022. The table below presents supplemental information related to operating leases for the six months ended July 31, 2023 (in thousands, except weighted-average information): Weighted-average remaining lease term (in years) 1.06 Weighted-average discount rate 3.7 % Cash paid for amounts included in the measurement of lease liabilities $ 316 Selected Financial Information Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Revenue $ 1,609 $ 1,020 $ 3,073 $ 2,113 Cost of revenue 560 413 1,051 712 Gross profit 1,049 607 2,022 1,401 Operating expenses: Sales and marketing 1,960 1,865 4,044 3,252 Research and development 727 1,909 2,683 2,837 General and administrative 1,407 3,539 (37) 4,293 Total operating expenses 4,094 7,313 6,690 10,382 Loss from operations (3,045) (6,706) (4,668) (8,981) Interest income 240 142 555 210 Other income, net 293 339 562 1,012 Net loss before income taxes (2,512) (6,225) (3,551) (7,759) Net loss $ (2,512) $ (6,225) $ (3,551) $ (7,759) Net loss attributable to noncontrolling interest $ (1,128) $ (2,473) $ (1,558) $ (2.987) July 31, 2023 January 31, 2023 Cash and cash equivalents $ 47,671 $ 56,744 Property and equipment, net 848 1,135 Operating lease right-of-use assets 673 998 Other assets 3,273 3,950 Total assets $ 52,465 $ 62,827 Total liabilities $ 7,277 $ 8,871 Equity Method Investment In April 2021, the Company reorganized Meltano Inc. (“Meltano”), which started as an internal project within the Company in July 2018, into a separate legal entity. The entity was funded by the Company’s contribution of intellectual property with the fair value of approximately $0.4 million and a preferred stock financing from third parties of $4.2 million, representing 12% ownership on a fully diluted basis. On April 4, 2022, Meltano closed its Series Seed-2 round of preferred stock financing and raised $7.2 million. Pursuant to this transaction, the board composition of Meltano changed and the Company no longer has the power to appoint the majority of the board of directors of Meltano. Consequently, despite having majority voting rights at the stockholder level, the Company no longer has control over Meltano. The loss of control of a majority owned subsidiary resulted in the deconsolidation of net assets of $9.4 million and non-controlling interest of Meltano of $11.3 million, recognition of retained interest at fair value of $15.9 million , and a gain of $17.8 million recorded in other income (expense), net in April 2022 . The fair value of retained interest was determined using the Option Pricing Model (“OPM”) Backsolve approach based on the most recent funding round of preferred stock. As of the date of the loss of control, the basis difference between the fair value of investment in Meltano and the Company’s share in the net assets of Meltano was attributed to equity method goodwill. Effective April 4, 2022, the Company accounts for this investment under the equity method and has recorded $10.6 million in “equity method investment” on its condensed consolidated balance sheet as of July 31, 2023. During the three and six months ended July 31, 2023, the Company recognized a loss from equity method investment of $0.9 million and $1.7 million, net of tax on the condensed consolidated statements of operations, respectively. During the three and six months ended July 31, 2022, the Company recognized a loss from equity method investment of $0.8 million and $1.0 million, net of tax on the condensed consolidated statements of operations, respectively. As of July 31, 2023, the Company owns 93% of the common stock in Meltano. As of July 31, 2023, Meltano has 3.3 million employee stock options and 3.1 million shares of preferred stock outstanding that are potentially dilutive equity instruments and will result in dilution to 46% in the Company’s stake in Meltano once all these instruments get converted into common stock of Meltano.

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	13. Income Taxes For the three and six months ended July 31, 2023, the Company recorded income tax expense of $4.0 million and $5.5 million on pretax loss of $46.3 million and $96.9 million , respectively. The income tax expense for the three and six months ended July 31, 2023 was primarily related to an increase in tax expense for unrecognized tax benefits and the Company's foreign and domestic operations as compared to the same periods last year. For the three and six months ended July 31, 2022, the Company recorded income tax benefit of $0.1 million and income tax expense of $2.5 million on pretax loss of $60.7 million and $84.6 million, respectively. The income tax benefit for the three months ended July 31, 2022 was primarily related to an increase in domestic losses from operations as compared to the same period last year. The income tax expense for the six months ended July 31, 2022 related primarily to the Company's foreign and domestic operations and the establishment of a deferred tax liability relating to the deconsolidation of a majority-owned entity, Meltano, and simultaneous establishment of the Company's equity method investment. The Company's provision for income taxes is based on its worldwide estimated annualized effective tax rate, except for jurisdictions for which a loss is expected for the year and no benefit can be realized for those losses, jurisdictions for which forecasted pre-tax income or loss cannot be estimated, and the tax effect of discrete items occurring during the period. The tax provision for jurisdictions for which a forecast cannot be estimated is based on actual taxes and tax reserves for the quarter. Under the provisions of ASC 740, Income Taxes , the determination of the Company’s ability to recognize its deferred tax asset requires an assessment of both negative and positive evidence when determining the Company’s ability to recognize its deferred tax assets. The Company determined that it was not more likely than not that the Company could recognize certain deferred tax assets. The evidence evaluated by the Company included operating results during the most recent three-year period and future projections, with more weight given to historical results than expectations of future profitability, which are inherently uncertain. Certain entities’ net losses in recent periods represented sufficient negative evidence to require a valuation allowance against its net deferred tax assets. This valuation allowance will be evaluated periodically and could be reversed partially or totally if business results have sufficiently improved to support realization of deferred tax assets. As of July 31, 2023, unrecognized tax benefits approxim ated $8.1 million, of which $2.6 million would affect the Company’s effective tax rate if recognized. As of January 31, 2023, unrecognized tax benefits approximated $7.5 million, of which $0.5 million would affect the Company’s effective tax rate if recognized. The Company anticipates an immaterial amount of unrecognized tax benefits to reverse in the next 12 months. It is the Company’s policy to classify accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. Accrued interest and penalties were $0.2 million as of July 31, 2023 and $0.2 million as of January 31, 2023, respectively. At July 31, 2023, the Company’s U.S. federal 2019 through 2022 tax years were open and subject to potential examination in one or more jurisdictions. In addition, in the United States, any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examination. The Company is currently under examination in the Netherlands for tax years 2015 and 2016. The Company is currently unable to estimate the financial outcome of this examination due to its preliminary status. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. The Company continues to monitor the progress of ongoing discussions with tax authorities and the effect, if any, of the expected expiration of the statute of limitations in various taxing jurisdictions.

Net Loss per Share

Net Loss per Share	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Net Loss per Share	14. Net Loss per Share The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Numerator: Net loss attributable to GitLab $ (50,080) $ (59,024) $ (102,549) $ (85,123) Denominator: Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted 153,644 147,797 152,683 147,248 Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted $ (0.33) $ (0.40) $ (0.67) $ (0.58) Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): As of July 31, 2023 January 31, 2023 Shares subject to outstanding common stock options 9,933 12,686 Unvested restricted stock in connection with business combination 3 8 Unvested early exercised stock options 63 194 Unvested RSUs and PSUs 11,465 8,336 Shares subject to the ESPP 71 81 Total 21,535 21,305

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	15. Commitments and Contingencies Contractual Obligations and Commitments The Company’s purchase obligations of $169.4 million as of July 31, 2023, represent third-party non-cancelable hosting infrastructure agreements, subscription arrangements and other commitments used in the ordinary course of business to meet operational requirements. Loss Contingencies In accordance with ASC 450, Loss Contingencies, the Company accrues for contingencies when losses become probable and reasonably estimable. Accordingly, the Company has recorded an estimated liability related to certain labor matters regarding its use o f contractors in certain foreign countries. As of July 31, 2023 and January 31, 2023 , the estimated liability relating to these matters w as $2.6 million and $2.5 million recorded in other non-current liabilities on the condensed consolidated balance sheets, respectively. Warranties and Indemnifications The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the condensed consolidated financial statements. In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments. In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid. Legal Proceedings The Company is, and from time to time, may become involved in legal proceedings or be subject to claims arising in the ordinary course of its business. The Company is not presently a party to any legal proceedings that in the opinion of management, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, financial condition or operating results.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (50,080)	$ (59,024)	$ (102,549)	$ (85,123)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
	Jul. 31, 2023 shares	Jul. 31, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On June 26, 2023, Erin Mannix, the Company’s Principal Accounting Officer and Chief Accounting Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Mannix Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The Mannix Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Mannix Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units, so long as the market price of the Company’s common stock is higher than certain minimum threshold prices specified in the Mannix Rule 10b5-1 Plan, between December 20, 2023 and June 28, 2024. The aggregate number of shares of Class A common stock that will be available for sale under the Mannix Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 9,152, which reflects the aggregate maximum number of shares underlying Ms. Mannix’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The Mannix Rule 10b5-1 Plan includes a representation from Ms. Mannix to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Mannix Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Mannix Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Mannix Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Mannix was unaware, or with respect to any material nonpublic information acquired by Ms. Mannix or the Company after the date of the representation.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Erin Mannix [Member]
Trading Arrangements, by Individual
Name	Erin Mannix
Title	Principal Accounting Officer and Chief Accounting Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 26, 2023
Aggregate Available	9,152	9,152

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP.
Fiscal Year	Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal 2024 and 2023 refer to the fiscal year ending January 31, 2024 and the fiscal year ended January 31, 2023, respectively.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes, reserves for unrealized income tax benefits, valuation of intangibles assets and impairment of goodwill and equity method investments. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.
Fair Value of Financial Instruments	The Company determines fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instrumen ts such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models.

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Subscription—self-managed and SaaS $ 122,096 87 % $ 88,936 88 % $ 233,287 87 % $ 165,859 88 % Subscription—self-managed 86,659 62 66,896 66 166,246 62 126,615 67 SaaS 35,437 25 22,040 22 67,041 25 39,244 21 License—self-managed and other $ 17,485 13 % $ 12,105 12 % $ 33,172 13 % $ 22,589 12 % License—self-managed 14,624 11 10,009 10 27,979 11 18,786 10 Professional services and other 2,861 2 2,096 2 5,193 2 3,803 2 Total revenue $ 139,581 100 % $ 101,041 100 % $ 266,459 100 % $ 188,448 100 %
Revenue by Geographic Location	The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 United States $ 114,054 $ 84,123 $ 217,016 $ 156,397 Europe 22,245 14,750 43,202 27,738 Asia Pacific 3,282 2,168 6,241 4,313 Total revenue $ 139,581 $ 101,041 $ 266,459 $ 188,448

Cash, Cash Equivalents and Sh_2

Cash, Cash Equivalents and Short-Term Investments (Tables)	6 Months Ended
	Jul. 31, 2023
Cash and Cash Equivalents [Abstract]
Schedule of Short Term Investments	The following table summarizes the Company’s cash, cash equivalents and short-term investments by category (in thousands): As of July 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 126,196 $ — $ — $ 126,196 Money market funds 117,628 — — 117,628 U.S. Treasury securities 18,485 — — 18,485 Commercial paper 10,919 — (3) 10,916 Total cash and cash equivalents $ 273,228 $ — $ (3) $ 273,225 Short-term investments: Commercial paper 83,957 — (77) 83,880 Corporate debt securities 177,000 2 (1,148) 175,854 Foreign government bonds 2,235 — (19) 2,216 U.S. Agency securities 67,567 — (445) 67,122 U.S. Treasury securities 385,848 1 (1,863) 383,986 Total short-term investments $ 716,607 $ 3 $ (3,552) $ 713,058 As of January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 232,332 $ — $ — $ 232,332 Money market funds 60,073 — — 60,073 U.S. Agency securities 2,997 — — 2,997 Total cash and cash equivalents $ 295,402 $ — $ — $ 295,402 Short-term investments: Commercial paper 88,703 18 (112) 88,609 Corporate debt securities 95,805 33 (572) 95,266 Municipal bonds 1,989 — (19) 1,970 Foreign government bonds 2,211 — (41) 2,170 U.S. Agency securities 74,158 2 (435) 73,725 U.S. Treasury securities 383,238 — (3,729) 379,509 Total short-term investments $ 646,104 $ 53 $ (4,908) $ 641,249
Schedule of Unrealized Losses Cash Equivalents and Short Term Investment	The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands): Less Than 12 Months More Than 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses July 31, 2023 U.S. Agency securities $ 63,223 $ (444) $ 3,899 $ (1) $ 67,122 $ (445) Commercial paper 86,797 (80) — — 86,797 (80) Corporate debt securities 153,562 (969) 18,869 (179) 172,431 (1,148) Foreign government bonds — — 2,216 (19) 2,216 (19) U.S. Treasury securities 263,148 (906) 92,567 (957) 355,715 (1,863) Total cash equivalents and short-term investments $ 566,730 $ (2,399) $ 117,551 $ (1,156) $ 684,281 $ (3,555) Less Than 12 Months More Than 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses January 31, 2023 U.S. Agency securities $ 73,724 $ (435) $ — $ — $ 73,724 $ (435) Commercial paper 45,015 (112) — — $ 45,015 $ (112) Corporate debt securities 75,203 (572) — — $ 75,203 $ (572) Municipal bonds 1,970 (19) — — $ 1,970 $ (19) Foreign government bonds 2,170 (41) — — $ 2,170 $ (41) U.S. Treasury securities 379,509 (3,729) — — $ 379,509 $ (3,729) Total cash equivalents and short-term investments $ 577,591 $ (4,908) $ — $ — $ 577,591 $ (4,908)
Schedule of Short Term Investments by Contractual Maturity	The following table classifies the Company’s short-term investments by contractual maturities (in thousands): July 31, 2023 January 31, 2023 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 587,035 $ 584,491 $ 480,943 $ 477,520 Due between 1 year to 2 years 129,572 128,567 165,161 163,729 Total $ 716,607 $ 713,058 $ 646,104 $ 641,249

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value on Recurring Basis	Financial assets measured at fair value on a recurring basis are summarized below (in thousands): Level 1 Level 2 Level 3 Fair Value July 31, 2023 (1) Cash equivalents: Money market funds $ 117,628 $ — $ — $ 117,628 U.S. Treasury securities — 18,485 — 18,485 Commercial paper — 10,916 — 10,916 Short-term investments: Commercial paper — 83,880 — 83,880 Corporate debt securities — 175,854 — 175,854 Foreign government bonds — 2,216 — 2,216 U.S. Agency securities — 67,122 — 67,122 U.S. Treasury securities — 383,986 — 383,986 Total $ 117,628 $ 742,459 $ — $ 860,087 (1) Excludes $126.2 million in cash on the condensed consolidated balance sheet as of July 31, 2023. Level 1 Level 2 Level 3 Fair Value January 31, 2023 (1) Cash equivalents: Money market funds $ 60,073 $ — $ — $ 60,073 U.S. Agency securities — 2,997 — 2,997 Short-term investments: Commercial paper — 88,609 — 88,609 Corporate debt securities — 95,266 — 95,266 Municipal bonds — 1,970 — 1,970 Foreign government bonds — 2,170 — 2,170 U.S. Agency securities — 73,725 — 73,725 U.S. Treasury securities — 379,509 — 379,509 Total $ 60,073 $ 644,246 $ — $ 704,319 (1) Exclu des

Supplemental Financial Statem_2

Supplemental Financial Statement Information (Tables)	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): July 31, 2023 January 31, 2023 Prepaid software subscriptions $ 6,748 $ 7,771 Prepaid taxes 3,955 592 Prepaid expenses for the Company’s events 1,030 1,885 Prepaid insurance 1,003 3,199 Prepaid advertising costs 532 367 Other prepaid expenses 3,459 1,915 Restricted cash (1) — 2,500 Interest receivable 2,913 2,310 Revenue contract asset 2,473 1,532 Security and other deposits 1,290 510 Other current assets 2,650 1,746 Total prepaid expense and other current assets $ 26,053 $ 24,327 (1) Refer to “Note 7. Business Combination”.
Property, Plant and Equipment	Property and equipment, net of the following (in thousands): July 31, 2023 January 31, 2023 Computer and office equipment $ 9,140 $ 8,581 Leasehold improvements 1,148 1,208 10,288 9,789 Less: Accumulated depreciation (1) (6,208) (3,992) Total property and equipment, net (1) $ 4,080 $ 5,797 (1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment.
Schedule of Other Assets, Noncurrent	Other long-term assets consisted of the following (in thousands): July 31, 2023 January 31, 2023 Security and other deposits $ 3,377 $ 3,172 Deferred software implementation costs 395 594 Vendor receivables 1,026 132 Other long-term assets 62 189 Total other long-term assets $ 4,860 $ 4,087
Schedule of Accrued Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2023 January 31, 2023 Accrued expenses $ 11,547 $ 10,686 Customer refunds payable 3,471 3,465 Income taxes payable 3,455 859 Indirect taxes payable 2,487 4,498 ESPP employee contributions 2,176 2,967 Operating lease liabilities, current 617 716 Acquisition related consideration withheld in escrow (1) — 2,500 Other current liabilities 890 263 Total accrued expenses and other current liabilities $ 24,643 $ 25,954 (1) Refer to “Note 7. Business Combination”.
Schedule of Accounts Payable and Accrued Liabilities	Accrued compensation and benefits consisted of the following (in thousands): July 31, 2023 January 31, 2023 Payroll taxes payable $ 5,778 $ 3,013 Accrued commissions 5,067 8,512 Restructuring accrual and related charges (1) 155 — Other accrued team member related payables 12,504 9,251 Total accrued compensation and benefits $ 23,504 $ 20,776 (1) Refer to “Note 11. Restructuring and Other Related Charges”.
Schedule of Other Non-current Liabilities	Other non-current liabilities consisted of the following (in thousands): July 31, 2023 January 31, 2023 Acquisition related contingent cash consideration (1) $ 3,525 $ 3,443 Provision towards labor matters (2) 2,586 2,504 Deferred tax liabilities 758 849 Long term taxes payable 2,792 647 Early exercised options liability 835 1,800 Operating lease liabilities, non-current 138 413 Other non-current liabilities 140 168 Total other non-current liabilities $ 10,774 $ 9,824 (1) Refer to “Note 7. Business Combination”. (2) Refer to “Note 15. Commitments and Contingencies ”.
Schedule of Other Income, Net	Other income, net consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Gain from deconsolidation of Meltano Inc. (1) $ — $ — $ — $ 17,798 Foreign exchange gains (losses), net (1,268) 1,646 (994) 2,506 Other expenses, net (62) (146) (83) (356) Total other income (expense), net $ (1,330) $ 1,500 $ (1,077) $ 19,948 (1) Refer to “Note 12. Joint Venture and Equity Method Investment”.

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	6 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of July 31, 2023 and January 31, 2023 $ 8,145
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): July 31, 2023 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (3,426) $ 2,774 1.3 Developed technology from asset acquisitions (1) (2) 932 (932) — 0.0 Total $ 7,132 $ (4,358) $ 2,774 January 31, 2023 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (2,401) $ 3,799 1.8 Developed technology from asset acquisitions (1) 1,359 (1,257) 102 0.3 Total $ 7,559 $ (3,658) $ 3,901 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles. (2) During the three months ended July 31, 2023 , t he Company wrote off $0.5 million of fully amortized intangible assets as the technology had become obsolete.
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination	As of July 31, 2023, future a mortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2024 $ 1,039 2025 1,735 Total future amortization $ 2,774

Equity (Tables)

Equity (Tables)	6 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Schedule of Stock Reserved For Future Issuance	The Company had shares of common stock reserved for future issuance as follows (in thousands): July 31, 2023 January 31, 2023 Class A and Class B common stock Options issued and outstanding 9,933 12,686 Shares available for issuance under Equity Incentive Plans 25,669 21,483 RSUs and PSUs issued and outstanding 11,376 8,336 Shares reserved for issuance to charitable organizations 1,502 1,636 ESPP 5,567 4,303 Total 54,047 48,444
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): July 31, 2023 January 31, 2023 Available at beginning of period 21,483 18,248 Awards authorized 7,557 7,673 RSUs and PSUs granted (4,843) (6,651) RSUs and PSUs canceled and forfeited 766 657 Options canceled and forfeited 691 1,496 Options repurchased 15 60 Available at end of period 25,669 21,483
Share-based Payment Arrangement, Option, Activity	The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2023 12,686 $ 12.30 7.00 $ 470.8 Options granted — — Options exercised (2,062) 8.74 Options canceled (198) 9.76 Options forfeited (493) 16.96 Balances at July 31, 2023 9,933 $ 12.80 6.56 $ 372.3 Options vested at July 31, 2023 6,528 $ 10.66 6.17 $ 254.4 Options vested and expected to vest at July 31, 2023 9,933 $ 12.80 6.56 $ 372.3
Schedule of Restricted Stock Units Activity	The following table summarizes the Company’s RSU activity (in thousands): Number of Shares (1) Weighted- Balances at January 31, 2023 5,018 $ 53.33 Granted 4,843 39.91 Vested (1,037) 49.97 Canceled/forfeited (677) 52.08 Balances at July 31, 2023 8,147 $ 45.90
Schedule of Estimating the Fair Value of the ESPP	The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model: Six Months Ended July 31, 2023 2022 Risk-free interest rate 4.22% - 5.30% 1.62% - 2.63% Volatility 40.95% - 51.00% 44.95% - 52.76% Expected term (in years) 0.50 - 2.00 0.50 - 2.00 Dividend yield —% —%
Schedule of Share Based Compensation Expense	The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Cost of revenue $ 1,698 $ 1,585 $ 3,112 $ 2,375 Research and development 12,477 11,339 24,179 16,375 Sales and marketing 21,295 14,851 35,059 21,902 General and administrative 10,898 9,972 16,348 14,566 Total stock-based compensation expense (1) $ 46,368 $ 37,747 $ 78,698 $ 55,218 (1) The table above includes stock-based compensation of JiHu. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Restructuring and Other Relat_2

Restructuring and Other Related Charges (Tables)	6 Months Ended
	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Charges	The Company recognized one-time severance and other termination benefit costs as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2023 Cost of revenue $ 46 $ 463 Research and development (12) 2,047 Sales and marketing 118 3,677 General and administrative 20 1,638 Total (1) $ 172 $ 7,825 (1) Excludes stock-based compensation of $1.3 million.
Schedule of Restructuring Reserve by Type of Cost	The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands) : Balance as of January 31, 2023 $ — Charges (1) 7,825 Cash payments (7,670) Balance as of July 31, 2023 (2) $ 155 (1) Excludes stock-based compensation of $1.3 million. (2) $0.2 million is included in accrued compensation and benefits on the condensed consolidated balance sheet as of July 31, 2023.

Joint Venture and Equity Meth_2

Joint Venture and Equity Method Investment (Tables)	6 Months Ended
	Jul. 31, 2023
Noncontrolling Interest [Abstract]
Schedule of Supplemental Information Related to Operating Leases	The table below presents supplemental information related to operating leases for the six months ended July 31, 2023 (in thousands, except weighted-average information): Weighted-average remaining lease term (in years) 1.06 Weighted-average discount rate 3.7 % Cash paid for amounts included in the measurement of lease liabilities $ 316
Schedule of Variable Interest Entities	Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Revenue $ 1,609 $ 1,020 $ 3,073 $ 2,113 Cost of revenue 560 413 1,051 712 Gross profit 1,049 607 2,022 1,401 Operating expenses: Sales and marketing 1,960 1,865 4,044 3,252 Research and development 727 1,909 2,683 2,837 General and administrative 1,407 3,539 (37) 4,293 Total operating expenses 4,094 7,313 6,690 10,382 Loss from operations (3,045) (6,706) (4,668) (8,981) Interest income 240 142 555 210 Other income, net 293 339 562 1,012 Net loss before income taxes (2,512) (6,225) (3,551) (7,759) Net loss $ (2,512) $ (6,225) $ (3,551) $ (7,759) Net loss attributable to noncontrolling interest $ (1,128) $ (2,473) $ (1,558) $ (2.987) July 31, 2023 January 31, 2023 Cash and cash equivalents $ 47,671 $ 56,744 Property and equipment, net 848 1,135 Operating lease right-of-use assets 673 998 Other assets 3,273 3,950 Total assets $ 52,465 $ 62,827 Total liabilities $ 7,277 $ 8,871

Net Loss per Share (Tables)

Net Loss per Share (Tables)	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Numerator: Net loss attributable to GitLab $ (50,080) $ (59,024) $ (102,549) $ (85,123) Denominator: Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted 153,644 147,797 152,683 147,248 Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted $ (0.33) $ (0.40) $ (0.67) $ (0.58)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): As of July 31, 2023 January 31, 2023 Shares subject to outstanding common stock options 9,933 12,686 Unvested restricted stock in connection with business combination 3 8 Unvested early exercised stock options 63 194 Unvested RSUs and PSUs 11,465 8,336 Shares subject to the ESPP 71 81 Total 21,535 21,305

Revenues - Disaggregation of Re

Revenues - Disaggregation of Revenue by Product and Service (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 139,581	$ 101,041	$ 266,459	$ 188,448
Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100%	100%	100%	100%
Subscription—self-managed and SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 122,096	$ 88,936	$ 233,287	$ 165,859
Subscription—self-managed and SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	87%	88%	87%	88%
Subscription—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 86,659	$ 66,896	$ 166,246	$ 126,615
Subscription—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	62%	66%	62%	67%
SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 35,437	$ 22,040	$ 67,041	$ 39,244
SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	25%	22%	25%	21%
License—self-managed and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 17,485	$ 12,105	$ 33,172	$ 22,589
License—self-managed and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	13%	12%	13%	12%
License—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 14,624	$ 10,009	$ 27,979	$ 18,786
License—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	11%	10%	11%	10%
Professional services and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 2,861	$ 2,096	$ 5,193	$ 3,803
Professional services and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	2%	2%	2%	2%

Revenues - Disaggregation of _2

Revenues - Disaggregation of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 139,581	$ 101,041	$ 266,459	$ 188,448
United States
Disaggregation of Revenue [Line Items]
Total revenue	114,054	84,123	217,016	156,397
Europe
Disaggregation of Revenue [Line Items]
Total revenue	22,245	14,750	43,202	27,738
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 3,282	$ 2,168	$ 6,241	$ 4,313

Revenues - Narrative (Details)

Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Disaggregation of Revenue [Line Items]
Deferred revenue recognized	$ 101.6	$ 67	$ 157.5	$ 105.8
Remaining performance obligation	$ 495.8		$ 495.8		$ 435.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-08-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, next twelve months (as a percent)	68%		68%
Remaining performance obligation, next twenty four months (as a percent)	88%		88%
Accounts Receivable | Credit Concentration Risk | Distribution Channel One
Disaggregation of Revenue [Line Items]
Concentration risk, percentage			16%		12%
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	82%	83%	81%	83%

Cash, Cash Equivalents and Sh_3

Cash, Cash Equivalents and Short-Term Investments - Schedule of Cash and Short Term Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 716,607	$ 646,104
Gross Unrealized Gains	3	53
Gross Unrealized Losses	(3,552)	(4,908)
Fair Value	713,058	641,249
Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	273,228	295,402
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(3)	0
Fair Value	273,225	295,402
Cash | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	126,196	232,332
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	126,196	232,332
Money market funds | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	117,628	60,073
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	117,628	60,073
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	385,848	383,238
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(1,863)	(3,729)
Fair Value	383,986	379,509
U.S. Treasury securities | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	18,485
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Fair Value	18,485
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	83,957	88,703
Gross Unrealized Gains	0	18
Gross Unrealized Losses	(77)	(112)
Fair Value	83,880	88,609
Commercial paper | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	10,919
Gross Unrealized Gains	0
Gross Unrealized Losses	(3)
Fair Value	10,916
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	177,000	95,805
Gross Unrealized Gains	2	33
Gross Unrealized Losses	(1,148)	(572)
Fair Value	175,854	95,266
U.S. Agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	67,567	74,158
Gross Unrealized Gains	0	2
Gross Unrealized Losses	(445)	(435)
Fair Value	67,122	73,725
U.S. Agency securities | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		2,997
Gross Unrealized Gains		0
Gross Unrealized Losses		0
Fair Value		2,997
Municipal bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		1,989
Gross Unrealized Gains		0
Gross Unrealized Losses		(19)
Fair Value		1,970
Foreign government bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,235	2,211
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(19)	(41)
Fair Value	$ 2,216	$ 2,170

Cash, Cash Equivalents and Sh_4

Cash, Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Cash and Cash Equivalents [Abstract]
Interest and investment income	$ 9,100	$ 3,100	$ 16,400	$ 3,600
Net amortization of premiums or discounts on short-term investments	4,900	$ 1,300	8,494	$ 1,293
More than 12 months or greater, carrying value	$ 117,551		$ 117,551		$ 0

Cash, Cash Equivalents and Sh_5

Cash, Cash Equivalents and Short-Term Investments - Schedule of Unrealized Losses Cash Equivalents and Short Term Investment (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	$ 566,730	$ 577,591
Less than 12 months, gross unrealized losses	(2,399)	(4,908)
More than 12 months or greater, carrying value	117,551	0
More than 12 months or greater, gross unrealized losses	(1,156)	0
Fair Value	684,281	577,591
Gross Unrealized Losses	(3,555)	(4,908)
U.S. Agency securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	63,223	73,724
Less than 12 months, gross unrealized losses	(444)	(435)
More than 12 months or greater, carrying value	3,899	0
More than 12 months or greater, gross unrealized losses	(1)	0
Fair Value	67,122	73,724
Gross Unrealized Losses	(445)	(435)
Commercial paper
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	86,797	45,015
Less than 12 months, gross unrealized losses	(80)	(112)
More than 12 months or greater, carrying value	0	0
More than 12 months or greater, gross unrealized losses	0	0
Fair Value	86,797	45,015
Gross Unrealized Losses	(80)	(112)
Corporate debt securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	153,562	75,203
Less than 12 months, gross unrealized losses	(969)	(572)
More than 12 months or greater, carrying value	18,869	0
More than 12 months or greater, gross unrealized losses	(179)	0
Fair Value	172,431	75,203
Gross Unrealized Losses	(1,148)	(572)
Municipal bonds
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value		1,970
Less than 12 months, gross unrealized losses		(19)
More than 12 months or greater, carrying value		0
More than 12 months or greater, gross unrealized losses		0
Fair Value		1,970
Gross Unrealized Losses		(19)
Foreign government bonds
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	0	2,170
Less than 12 months, gross unrealized losses	0	(41)
More than 12 months or greater, carrying value	2,216	0
More than 12 months or greater, gross unrealized losses	(19)	0
Fair Value	2,216	2,170
Gross Unrealized Losses	(19)	(41)
U.S. Treasury securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	263,148	379,509
Less than 12 months, gross unrealized losses	(906)	(3,729)
More than 12 months or greater, carrying value	92,567	0
More than 12 months or greater, gross unrealized losses	(957)	0
Fair Value	355,715	379,509
Gross Unrealized Losses	$ (1,863)	$ (3,729)

Cash, Cash Equivalents and Sh_6

Cash, Cash Equivalents and Short-Term Investments - Schedule of Short Term Investments by Contractual Maturity (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Amortized cost
Due within 1 year	$ 587,035	$ 480,943
Due between 1 year to 2 years	129,572	165,161
Total	716,607	646,104
Fair Value
Due within 1 year	584,491	477,520
Due between 1 year to 2 years	128,567	163,729
Total	$ 713,058	$ 641,249

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	$ 713,058	$ 641,249
Cash held in bank accounts	716,607	646,104
Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	273,225	295,402
Cash held in bank accounts	273,228	295,402
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	860,087	704,319
Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	117,628	60,073
Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	742,459	644,246
Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	0	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	83,880	88,609
Cash held in bank accounts	83,957	88,703
Commercial paper | Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	10,916
Cash held in bank accounts	10,919
Commercial paper | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	83,880	88,609
Commercial paper | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Commercial paper | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	83,880	88,609
Commercial paper | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	175,854	95,266
Cash held in bank accounts	177,000	95,805
Corporate debt securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	175,854	95,266
Corporate debt securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Corporate debt securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	175,854	95,266
Corporate debt securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		1,970
Cash held in bank accounts		1,989
Municipal bonds | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		1,970
Municipal bonds | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		0
Municipal bonds | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		1,970
Municipal bonds | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		0
Foreign government bonds | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	2,216	2,170
Foreign government bonds | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Foreign government bonds | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	2,216	2,170
Foreign government bonds | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
U.S. Agency securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	67,122	73,725
U.S. Agency securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
U.S. Agency securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	67,122	73,725
U.S. Agency securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	383,986	379,509
Cash held in bank accounts	385,848	383,238
U.S. Treasury securities | Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	18,485
Cash held in bank accounts	18,485
U.S. Treasury securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	383,986	379,509
U.S. Treasury securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
U.S. Treasury securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	383,986	379,509
U.S. Treasury securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Cash | Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	126,196	232,332
Cash held in bank accounts	126,196	232,332
Money market funds | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	117,628	60,073
Money market funds | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	117,628	60,073
Money market funds | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Money market funds | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
U.S. Treasury securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	18,485
U.S. Treasury securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Treasury securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	18,485
U.S. Treasury securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Commercial paper | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	10,916
Commercial paper | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Commercial paper | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	10,916
Commercial paper | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 0
U.S. Agency securities | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		2,997
U.S. Agency securities | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		0
U.S. Agency securities | Fair Value, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		2,997
U.S. Agency securities | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	Jul. 31, 2023	Jan. 31, 2023
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent cash consideration	$ 3.5	$ 3.4

Supplemental Financial Statem_3

Supplemental Financial Statement Information - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands		Jul. 31, 2023	Jan. 31, 2023	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid software subscriptions		$ 6,748	$ 7,771
Prepaid taxes		3,955	592
Prepaid expenses for the Company’s events		1,030	1,885
Prepaid insurance		1,003	3,199
Prepaid advertising costs		532	367
Other prepaid expenses		3,459	1,915
Restricted cash		0	2,500	$ 2,500
Interest receivable		2,913	2,310
Revenue contract asset		2,473	1,532
Security and other deposits		1,290	510
Other current assets		2,650	1,746
Total prepaid expense and other current assets	[1]	$ 26,053	$ 24,327
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_4

Supplemental Financial Statement Information - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 10,288		$ 10,288		$ 9,789
Less: Accumulated depreciation		(6,208)		(6,208)		(3,992)
Property and equipment, net	[1]	4,080		4,080		5,797
Depreciation expense		1,100	$ 700	2,200	$ 1,300
Computer and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross		9,140		9,140		8,581
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 1,148		$ 1,148		$ 1,208
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_5

Supplemental Financial Statement Information - Schedule of Other Long-Term Assets (Details) - USD ($) $ in Thousands		Jul. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Security and other deposits		$ 3,377	$ 3,172
Deferred software implementation costs		395	594
Vendor receivables		1,026	132
Other long-term assets		62	189
Total other long-term assets	[1]	$ 4,860	$ 4,087
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_6

Supplemental Financial Statement Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands		Jul. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses		$ 11,547	$ 10,686
Customer refunds payable		3,471	3,465
Income taxes payable		3,455	859
Indirect taxes payable		2,487	4,498
ESPP employee contributions		2,176	2,967
Operating lease liabilities, current		$ 617	$ 716
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Total accrued expenses and other current liabilities	Total accrued expenses and other current liabilities
Acquisition related consideration withheld in escrow		$ 0	$ 2,500
Other current liabilities		890	263
Total accrued expenses and other current liabilities	[1]	$ 24,643	$ 25,954
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_7

Supplemental Financial Statement Information - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Payroll taxes payable	$ 5,778	$ 3,013
Accrued commissions	5,067	8,512
Restructuring accrual and related charges	155	0
Other accrued team member related payables	12,504	9,251
Total accrued compensation and benefits	$ 23,504	$ 20,776

Supplemental Financial Statem_8

Supplemental Financial Statement Information - Other Non-Current Liabilities (Details) - USD ($) $ in Thousands		Jul. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Acquisition related contingent cash consideration		$ 3,525	$ 3,443
Provision towards labor matters		2,586	2,504
Deferred tax liabilities		758	849
Long term taxes payable		2,792	647
Early exercised options liability		835	1,800
Operating lease liabilities, non-current		$ 138	$ 413
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Total other non-current liabilities	Total other non-current liabilities
Other non-current liabilities		$ 140	$ 168
Total other non-current liabilities	[1]	$ 10,774	$ 9,824
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_9

Supplemental Financial Statement Information - Other Income, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Gain from deconsolidation of Meltano Inc.	$ 0	$ 0	$ 0	$ 17,798
Foreign exchange gains (losses), net	(1,268)	1,646	(994)	2,506
Other expenses, net	(62)	(146)	(83)	(356)
Total other income (expense), net	$ (1,330)	$ 1,500	$ (1,077)	$ 19,948

Business Combination - Narrativ

Business Combination - Narrative (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 03, 2021	Sep. 30, 2022	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Business Acquisition [Line Items]
Acquisition related contingent cash consideration			$ 3,525		$ 3,525		$ 3,443
Accretion expense			0	$ 100	100	$ 200
Opstrace Inc.
Business Acquisition [Line Items]
Business combination, consideration transferred	$ 13,500
Cash consideration held back							$ 2,500
Post-closing indemnification term							18 months
Partial settlement of acquisition related contingent cash consideration		$ 4,200
Acquisition related contingent cash consideration			$ 3,500		$ 3,500		$ 3,500

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Rollforward of Goodwill (Details) - USD ($) $ in Thousands		Jul. 31, 2023	Jan. 31, 2023
Goodwill [Roll Forward]
Goodwill	[1]	$ 8,145	$ 8,145
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment			$ 0		$ 0
Amortization of intangible assets	$ 500,000	$ 600,000	$ 1,125,000	$ 1,176,000

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Jul. 31, 2023	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 7,132	$ 7,559
Accumulated Amortization	(4,358)	(3,658)
Net Book Value	2,774	3,901
Write-off of fully amortized intangible assets	500
Developed technology from business combination
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	6,200	6,200
Accumulated Amortization	(3,426)	(2,401)
Net Book Value	$ 2,774	$ 3,799
Weighted average remaining amortization period (years)	1 year 3 months 18 days	1 year 9 months 18 days
Developed technology from asset acquisitions
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 932	$ 1,359
Accumulated Amortization	(932)	(1,257)
Net Book Value	$ 0	$ 102
Weighted average remaining amortization period (years)	0 years	3 months 18 days

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 1,039
2025	1,735
Total future amortization	$ 2,774	$ 3,901

Team Member Benefit Plans (Deta

Team Member Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Retirement Benefits [Abstract]
Defined contribution plan, contribution amount	$ 1	$ 0.8	$ 2.7	$ 2

Equity - Narrative (Details)

Equity - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022 shares	May 31, 2021 USD ($) shares	Jul. 31, 2023 USD ($) vote $ / shares shares	Jul. 31, 2022 USD ($) shares	Jul. 31, 2023 USD ($) vote $ / shares shares	Jul. 31, 2022 USD ($) shares	Jan. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2023 USD ($)	Oct. 18, 2021 $ / shares shares	Sep. 30, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in shares) | shares			50,000,000		50,000,000		50,000,000		50,000,000
Preferred stock, par value (in USD per share) | $ / shares			$ 0.0000025		$ 0.0000025		$ 0.0000025		$ 0.0000025
Shares subject to repurchase obligation (in shares) | shares			62,712		62,712		194,304
Deferred compensation liability, noncurrent			$ 800		$ 800		$ 1,800
Options granted (in shares) | shares			0	0	0	0
Intrinsic value of options exercised			$ 33,300	$ 25,800	$ 65,900	$ 59,800
Compensation expense not yet recognized			32,000		32,000		$ 46,200
Total stock-based compensation expense			46,368	37,747	$ 78,698	$ 55,218
Grant date fair value of RSUs granted		$ 8,800
Offering period					24 months	24 months
Tax benefit for stock-based compensation expense			3,600	2,200	$ 6,400	$ 3,100
Charitable donation of common stock			2,675		$ 5,350
Shares subject to outstanding common stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)					1 year 9 months 18 days		2 years 1 month 6 days
Shares subject to outstanding common stock options | 2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (in years)					10 years
Shares subject to outstanding common stock options | 2015 Equity Incentive Plan | Period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage					25%
Award vesting period (in years)					1 year
Shares subject to outstanding common stock options | 2015 Equity Incentive Plan | Period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)					36 months
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense not yet recognized			362,000		$ 362,000		$ 254,800
Period for recognition (in years)					3 years 3 months 18 days		3 years 2 months 12 days
RSUs | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)					5 years 3 months 18 days
Total stock-based compensation expense			400	400	$ 800	800
Compensation expense not yet recognized			5,100		$ 5,100
RSUs | Minimum | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)					2 years
RSUs | Maximum | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)					7 years
RSUs | 2021 Equity Incentive Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)					2 years
RSUs | 2021 Equity Incentive Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)					4 years
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	100%
Period for recognition (in years)					2 years 4 months 24 days
RSUs granted in period (in shares) | shares	400,000
Total stock-based compensation expense			(100)		$ 300
Compensation expense not yet recognized			6,300		$ 6,300
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	0%
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	200%
ESPP | 2021 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)					1 year 9 months 18 days
Total stock-based compensation expense			6,700	9,700	$ 11,200	14,100
Compensation expense not yet recognized			19,800		19,800
Plan modification, cost not yet recognized			$ 9,400	$ 9,900	$ 9,400	$ 9,900
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares) | shares			1,500,000,000		1,500,000,000		1,500,000,000		1,500,000,000
Common stock, par value (in USD per share) | $ / shares			$ 0.0000025		$ 0.0000025		$ 0.0000025		$ 0.0000025
Voting rights, vote per share | vote			1		1
Common stock reserved for future issuance (in shares) | shares										1,635,545
Aggregate principal amount, donation								$ 10,700
Charitable donation of common stock (in shares) | shares			52,647		133,389
Charitable donation of common stock			$ 2,700		$ 5,300
Class A Common Stock | 2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (in shares) | shares										13,032,289
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares) | shares			250,000,000		250,000,000		250,000,000		250,000,000
Common stock, par value (in USD per share) | $ / shares			$ 0.0000025		$ 0.0000025		$ 0.0000025		$ 0.0000025
Voting rights, vote per share | vote			10		10
Class B Common Stock | RSUs | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs granted in period (in shares) | shares		3,000,000

Equity - Schedule of Stock Rese

Equity - Schedule of Stock Reserved For Future Issuance (Details) - shares shares in Thousands	Jul. 31, 2023	Jan. 31, 2023	Jan. 31, 2022
Class of Stock [Line Items]
Options issued and outstanding (in shares)	9,933	12,686
Shares available for issuance under Equity Incentive Plans (in shares)	25,669	21,483	18,248
Class A and Class B common stock
Class of Stock [Line Items]
Options issued and outstanding (in shares)	9,933	12,686
Shares available for issuance under Equity Incentive Plans (in shares)	25,669	21,483
Shares reserved for issuance to charitable organizations (in shares)	1,502	1,636
Common stock reserved for future issuance (in shares)	54,047	48,444
RSUs and PSUs | Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	11,376	8,336
ESPP | Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	5,567	4,303

Equity - Awards Available for G

Equity - Awards Available for Grant (Details) - shares shares in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2023	Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
Balance, beginning of period (in shares)	21,483	18,248
Awards authorized (in shares)	7,557	7,673
Options cancelled and forfeited (in shares)	691	1,496
Options repurchased (in shares)	15	60
Balance, end of period (in shares)	25,669	21,483
RSUs and PSUs
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
RSUs and PSUs granted (in shares)	(4,843)	(6,651)
RSUs and PSUs cancelled and forfeited (in shares)	766	657

Equity - Summary of Stock Optio

Equity - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Number of Stock Options Outstanding (in thousands)
Balance, beginning of period (in shares)			12,686,000
Options granted (in shares)	0	0	0	0
Options exercised (in shares)			(2,062,000)
Options cancelled (in shares)			(198,000)
Options forfeited (in shares)			(493,000)
Balance, end of period (in shares)	9,933,000		9,933,000		12,686,000
Options vested (in shares)	6,528,000		6,528,000
Options expected to vest (in shares)	9,933,000		9,933,000
Weighted Average Exercise Price
Balance, beginning of period (in USD per share)			$ 12.30
Options granted (in USD per share)			0
Options exercised (in USD per share)			8.74
Options cancelled (in USD per share)			9.76
Options forfeited (in USD per share)			16.96
Balance, end of period (in USD per share)	$ 12.80		12.80		$ 12.30
Options vested (in USD per share)			10.66
Options expected to vest (in USD per share)			$ 12.80
Weighted Average Remaining Years
Outstanding (in years)			6 years 6 months 21 days		7 years
Options vested (in years)			6 years 2 months 1 day
Options expected to vest (in years)			6 years 6 months 21 days
Aggregate Intrinsic value (in millions)
Outstanding value	$ 372.3		$ 372.3		$ 470.8
Options vested	254.4		254.4
Options expected to vest	$ 372.3		$ 372.3

Equity - Schedule of Restricted

Equity - Schedule of Restricted Stock Units Activity (Details) - RSUs shares in Thousands	6 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Balance, beginning of period (in shares)	5,018
Granted (in shares)	4,843
Vested (in shares)	(1,037)
Canceled/forfeited (in shares)	(677)
Balance, ending of period (in shares)	8,147
Weighted- Average grant date fair value
Balance, beginning of period (in USD per share) | $ / shares	$ 53.33
Granted (in USD per share) | $ / shares	39.91
Vested (in USD per share) | $ / shares	49.97
Canceled/forfeited (in USD per share) | $ / shares	52.08
Balance, ending of period (in USD per share) | $ / shares	$ 45.90
Chief Executive Officer
Number of Shares
Granted (in shares)	3,000

Equity - Schedule of Weighted A

Equity - Schedule of Weighted Average Fair Value Assumptions (Details) - ESPP	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield (as a percent)	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (as a percent)	4.22%	1.62%
Volatility (as a percent)	40.95%	44.95%
Expected term (in years)	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (as a percent)	5.30%	2.63%
Volatility (as a percent)	51%	52.76%
Expected term (in years)	2 years	2 years

Equity - Stock-Based Compensati

Equity - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 46,368	$ 37,747	$ 78,698	$ 55,218
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	1,698	1,585	3,112	2,375
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	12,477	11,339	24,179	16,375
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	21,295	14,851	35,059	21,902
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 10,898	$ 9,972	$ 16,348	$ 14,566

Restructuring and Other Relat_3

Restructuring and Other Related Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2023
Restructuring Cost and Reserve [Line Items]
Positions eliminated, percent		7%
Restructuring charges			$ 9,100
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 172		7,825
One-time Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 1,300

Restructuring and Other Relat_4

Restructuring and Other Related Charges - Schedule of Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 9,100
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 172	7,825
One-time Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		1,300
Cost of revenue | Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	46	463
Research and development | Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(12)	2,047
Sales and marketing | Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	118	3,677
General and administrative | Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 20	$ 1,638

Restructuring and Other Relat_5

Restructuring and Other Related Charges - Restructuring Accrual (Details) $ in Thousands	3 Months Ended	6 Months Ended
	Jul. 31, 2023 USD ($)	Jul. 31, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance		$ 0
Charges		9,100
Ending balance	$ 155	155
Restructuring reserve	200	200
One-time Termination Benefits
Restructuring Reserve [Roll Forward]
Charges		1,300
Employee Severance
Restructuring Reserve [Roll Forward]
Beginning balance		0
Charges	172	7,825
Cash payments		(7,670)
Ending balance	$ 155	$ 155

Joint Venture and Equity Meth_3

Joint Venture and Equity Method Investment - Narrative (Details) $ in Thousands, shares in Millions			1 Months Ended			3 Months Ended		6 Months Ended		12 Months Ended
		Apr. 04, 2022 USD ($)	Apr. 30, 2022 USD ($)	Mar. 31, 2022 USD ($) day	Apr. 30, 2021 USD ($)	Jul. 31, 2023 USD ($)	Jul. 31, 2022 USD ($)	Jul. 31, 2023 USD ($) shares	Jul. 31, 2022 USD ($)	Jan. 31, 2023 USD ($)	Jan. 31, 2022
Noncontrolling Interest [Line Items]
Total stock-based compensation expense						$ 46,368	$ 37,747	$ 78,698	$ 55,218
Operating lease expense						$ 100	200	$ 300	300
Operating lease, remaining term (in years)						2 years		2 years
Operating lease, total lease payments						$ 700		$ 700
Operating lease liabilities						700		700
Contributions received from noncontrolling interests, net of issuance costs								0	57,673
Decrease from deconsolidation									11,342
Gain from deconsolidation of Meltano Inc.						0	0	0	17,798
Equity method investment	[1]					10,574		10,574		$ 12,682
Loss from equity method investment, net of tax						917	816	1,665	1,019
Noncontrolling Interests
Noncontrolling Interest [Line Items]
Decrease from deconsolidation									11,342
Meltano Inc.
Noncontrolling Interest [Line Items]
Gain from deconsolidation of Meltano Inc.			$ 17,800
Equity method investment						10,600		10,600
Loss from equity method investment, net of tax						$ 900	800	$ 1,700	1,000
Stake in equity method investment (as a percent)								93%
Meltano Inc. | Employee stock options
Noncontrolling Interest [Line Items]
Potentially dilutive equity instruments (in shares) | shares								3.3
Meltano Inc. | Preferred Stock
Noncontrolling Interest [Line Items]
Stake in equity method investment (as a percent)								46%
Potentially dilutive equity instruments (in shares) | shares								3.1
Meltano Inc. | Noncontrolling Interests
Noncontrolling Interest [Line Items]
Decrease in net assets upon consolidation		$ 9,400
Decrease from deconsolidation		11,300
Meltano Inc. | Accumulated Deficit
Noncontrolling Interest [Line Items]
Decrease from deconsolidation		15,900
GitLab Information Technology (Hubei) Co., LTD ("JiHu")
Noncontrolling Interest [Line Items]
Ownership percentage						55%		55%		55%	72%
Meltano Inc.
Noncontrolling Interest [Line Items]
Loan payable, period (in days)					$ 400
Ownership percentage by noncontrolling owners					12%
GitLab Information Technology (Hubei) Co., LTD ("JiHu")
Noncontrolling Interest [Line Items]
Consideration received on transaction, net										$ 54,600
Total stock-based compensation expense						$ (200)	$ 2,800	$ (2,700)	$ 3,000
Compensation expense not yet recognized						$ 4,300		$ 4,300
Period for recognition (in years)								2 years 8 months 12 days
GitLab Information Technology (Hubei) Co., LTD ("JiHu") | Variable Interest Entity, Primary Beneficiary
Noncontrolling Interest [Line Items]
Loans payable				$ 2,900
Loan payable, period (in days) | day				10
Meltano Inc.
Noncontrolling Interest [Line Items]
Consideration received on transaction, net		$ 7,200
Contributions received from noncontrolling interests, net of issuance costs					$ 4,200
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Joint Venture and Equity Meth_4

Joint Venture and Equity Method Investment - Supplemental Information Related to Operating Leases (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2023 USD ($)
Leases [Abstract]
Weighted-average remaining lease term (in years)	1 year 21 days
Weighted-average discount rate	3.70%
Cash paid for amounts included in the measurement of lease liabilities	$ 316

Joint Venture and Equity Meth_5

Joint Venture and Equity Method Investment - Schedule of Intercompany Eliminations (Details) - USD ($)		3 Months Ended			6 Months Ended
		Jul. 31, 2023		Jul. 31, 2022	Jul. 31, 2023		Jul. 31, 2022	Jan. 31, 2023
Noncontrolling Interest [Line Items]
Revenue		$ 139,581,000		$ 101,041,000	$ 266,459,000		$ 188,448,000
Cost of revenue		14,696,000		13,030,000	28,635,000		22,878,000
Gross profit		124,885,000		88,011,000	237,824,000		165,570,000
Sales and marketing		92,116,000		80,689,000	178,653,000		147,399,000
Research and development		49,007,000		39,520,000	99,394,000		71,350,000
Total operating expenses		178,942,000		153,313,000	350,114,000		273,745,000
Loss from operations		(54,057,000)		(65,302,000)	(112,290,000)		(108,175,000)
Interest income		9,112,000		3,064,000	16,427,000		3,590,000
Total other income (expense), net		(1,330,000)		1,500,000	(1,077,000)		19,948,000
Net loss		(51,208,000)		(61,497,000)	(104,107,000)		(88,110,000)
Net loss attributable to noncontrolling interest		(1,128,000)		(2,473,000)	(1,558,000)		(2,987,000)
Cash and cash equivalents		273,225,000	[1]	410,757,000	273,225,000	[1]	410,757,000	$ 295,402,000	[1]
Property and equipment, net	[1]	4,080,000			4,080,000			5,797,000
Operating lease right-of-use assets		673,000	[1]		673,000	[1]		998,000
TOTAL ASSETS	[1]	1,189,069,000			1,189,069,000			1,169,200,000
Total liabilities	[1]	357,829,000			357,829,000			344,475,000
Variable Interest Entity, Primary Beneficiary
Noncontrolling Interest [Line Items]
Revenue		1,609,000		1,020,000	3,073,000		2,113,000
Cost of revenue		560,000		413,000	1,051,000		712,000
Gross profit		1,049,000		607,000	2,022,000		1,401,000
Sales and marketing		1,960,000		1,865,000	4,044,000		3,252,000
Research and development		727,000		1,909,000	2,683,000		2,837,000
General and administrative		1,407,000		3,539,000	(37,000)		4,293,000
Total operating expenses		4,094,000		7,313,000	6,690,000		10,382,000
Loss from operations		(3,045,000)		(6,706,000)	(4,668,000)		(8,981,000)
Interest income		240,000		142,000	555,000		210,000
Total other income (expense), net		293,000		339,000	562,000		1,012,000
Net loss before income taxes		(2,512,000)		(6,225,000)	(3,551,000)		(7,759,000)
Net loss		(2,512,000)		(6,225,000)	(3,551,000)		(7,759,000)
Net loss attributable to noncontrolling interest		(1,128,000)		$ (2,473,000)	(1,558,000)		$ (2,987)
Cash and cash equivalents		47,671,000			47,671,000			56,744,000
Property and equipment, net		848,000			848,000			1,135,000
Operating lease right-of-use assets		673,000			673,000			998,000
Other assets		3,273,000			3,273,000			3,950,000
TOTAL ASSETS		52,465,000			52,465,000			62,827,000
Total liabilities		$ 7,277,000			$ 7,277,000			$ 8,871,000
[1] (1) As of July 31, 2023 and January 31, 2023, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $52.5 million and $62.8 million, respectively, and liabilities of $7.3 million and $8.9 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 12. Joint Venture and Equity Method Investment” for further discussion.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 4,016	$ (57)	$ 5,502	$ 2,454
Loss before income taxes and loss from equity method investment	46,275	$ 60,738	96,940	$ 84,637
Unrecognized tax benefits	8,100		8,100		$ 7,500
Unrecognized tax benefits that would effect tax rate	$ 2,600		2,600		500
Interest and penalties recognized			$ 200		$ 200

Net Loss per Share - Schedule o

Net Loss per Share - Schedule of Earning Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Earnings Per Share [Abstract]
Net loss attributable to GitLab, basic	$ (50,080)	$ (59,024)	$ (102,549)	$ (85,123)
Net loss attributable to GitLab, diluted	$ (50,080)	$ (59,024)	$ (102,549)	$ (85,123)
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in shares)	153,644,000	147,797,000	152,683,000	147,248,000
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in shares)	153,644,000	147,797,000	152,683,000	147,248,000
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)	$ (0.33)	$ (0.40)	$ (0.67)	$ (0.58)
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)	$ (0.33)	$ (0.40)	$ (0.67)	$ (0.58)

Net Loss per Share - Schedule_2

Net Loss per Share - Schedule of Potentially Dilutive Securities (Details) - shares shares in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2023	Jan. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	21,535	21,305
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	9,933	12,686
Unvested restricted stock in connection with business combination
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	3	8
Unvested early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	63	194
Unvested RSUs and PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	11,465	8,336
Shares subject to the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	71	81

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	Jul. 31, 2023	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation	$ 169.4
Estimate of possible loss	$ 2.6	$ 2.5